PharmaCompass

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

News

Quotient Sciences Extends Mfg Partnership For Ultra-Rare Disease

27 Feb 2026

// PRESS RELEASE

First-in-Human Is Not Just About Safety

09 Feb 2026

// PRESS RELEASE

VP Marlene Leuenberger on CPHI Online A Day in the Life

27 Jan 2026

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Contact Supplier

Website

Annual COG

Attending

Book a meeting

envelop Contact Supplier

CATEGORY PAGE

Quotient Sciences

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Corporate Presentation, Phase I/Clinical Pharmacology, Drug Product Development & Manufacturing Services, Clinical Pharmacology Services, First-in-Human (FIH) Trials to Proof of Concept (POC), Scalable Drug Product Manufacturing, Translational Pharmaceutics® for first-in-human studies, Inhaled Product Development, Aseptic Development and Manufacturing, Global Formulation Development & Manufacturing Capabilities, Pre-formulation and Material Sciences, Drug Substance Synthesis and Manufacturing, Modified-Release Formulation Strategies, First Subjects Dosing with VS-041 a Novel Heart Failure Treatment, 14C Human ADME Program for HTD1801, Oxilio & Quotient Announce Regulatory Approval for OXL001, Expansion of Facilities for Translational Pharmaceutics® Programs, Ensysce Biosciences & Quotient Announce a Partnership, Human ADME Studies, Bioanalytical Services, Translational Pharmaceutics®, Formulation Strategies for Poorly Soluble Molecules, Global Formulation Development & Manufacturing Capabilities, Commercial Manufacturing, Clinical Trial Manufacturing

Corporate Presentation
Phase I/Clinical Pharmacology
Drug Product Development & Manufacturing Services
Clinical Pharmacology Services
First-in-Human (FIH) Trials to Proof of Concept (POC)
Scalable Drug Product Manufacturing
Translational Pharmaceutics® for first-in-human studies
Inhaled Product Development
Aseptic Development and Manufacturing
Global Formulation Development & Manufacturing Capabilities
Pre-formulation and Material Sciences
Drug Substance Synthesis and Manufacturing
Modified-Release Formulation Strategies
First Subjects Dosing with VS-041 a Novel Heart Failure Treatment
14C Human ADME Program for HTD1801
Oxilio & Quotient Announce Regulatory Approval for OXL001
Expansion of Facilities for Translational Pharmaceutics® Programs
Ensysce Biosciences & Quotient Announce a Partnership
Human ADME Studies
Bioanalytical Services
Translational Pharmaceutics®
Formulation Strategies for Poorly Soluble Molecules
Global Formulation Development & Manufacturing Capabilities
Commercial Manufacturing
Clinical Trial Manufacturing

VIDEO(s)

Corporate Video, Bioanalysis, Clinical Pharmacology, Clinical Trial Manufacturing, Commercial Manufacturing, Data Sciences, Drug Development Consulting, Drug Substance, Formulation Development, Translational Pharmaceutics®, Bioanalytical Services, Candidate Molecule Selection, CDMO Solutions for Orphan & Rare Diseases, Early Development, Late Development, Orphan Drug Programs, What is Bioanalysis? (BioA), Our Manifesto, Miami Clinical Pharmacology Facility

Corporate Video
Bioanalysis
Clinical Pharmacology
Clinical Trial Manufacturing
Commercial Manufacturing
Data Sciences
Drug Development Consulting
Drug Substance
Formulation Development
Translational Pharmaceutics®
Bioanalytical Services
Candidate Molecule Selection
CDMO Solutions for Orphan & Rare Diseases
Early Development
Late Development
Orphan Drug Programs
What is Bioanalysis? (BioA)
Our Manifesto
Miami Clinical Pharmacology Facility

DIGITAL CONTENT

5 Interview #SpeakPharma, 44 Corporate Content #SupplierSpotlight, 3 Data Compilation #PharmaFlow, 161 News #PharmaBuzz

5 Interview #SpeakPharma
44 Corporate Content #SupplierSpotlight
3 Data Compilation #PharmaFlow
161 News #PharmaBuzz

DEVELOPMENTS

96 Drugs in Development

96 Drugs in Development

SERVICES

Analytical, Clinical Trials, API Manufacturing, Drug Product Manufacturing, API & Drug Product Development, Packaging

Analytical
- 1 BioAnalytical Services
- 1 Analytical Method Development
Clinical Trials
API Manufacturing
Drug Product Manufacturing
API & Drug Product Development
Packaging
- 5 Clinical Services

KEY SERVICES

Pharmacy Compounding Services, Pharmacy Compounding & Formulation, Formulation Development of Capsules, CDMO for Suspensions, Formulation Development of Tablets, Pediatric Formulation Development

Pharmacy Compounding Services
Pharmacy Compounding & Formulation
Formulation Development of Capsules
CDMO for Suspensions
Formulation Development of Tablets
Pediatric Formulation Development

INSPECTIONS & REGISTRATIONS

13 FDA, 7 EDQM, 1 GDUFA

13 FDA
7 EDQM
1 GDUFA

PI72998

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Phase I/Clinical Pharmacology services provided by Quotient Sciences

CATEGORY PAGE

Quotient Sciences

VIRTUAL BOOTH

CONTACT DETAILS

Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

PRESENTATION(s)

VIDEO(s)

DIGITAL CONTENT

5 Interview #SpeakPharma

44 Corporate Content #SupplierSpotlight

3 Data Compilation #PharmaFlow

161 News #PharmaBuzz

DEVELOPMENTS

96 Drugs in Development

SERVICES

Analytical

Clinical Trials

API Manufacturing

Drug Product Manufacturing

API & Drug Product Development

Packaging

KEY SERVICES

INSPECTIONS & REGISTRATIONS